Table 1.
Association Between KLF16 Expression and Clinicopathological Parameters in Breast Cancer Tissues (n=117)
| Parameters | KLF16 Expression | X2-Test p-value | ||
|---|---|---|---|---|
| Low (0–3) | Medium (4–7) | High (8–12) | ||
| Age | ||||
| ≤ 45 | 0 | 6 | 2 | 0.0114* |
| >45 | 14 | 28 | 67 | |
| pT | ||||
| 1 | 5 | 13 | 25 | 0.9992 |
| 2 | 8 | 19 | 40 | |
| 3 | 1 | 2 | 4 | |
| pN | ||||
| Negative | 12 | 19 | 46 | 0.1369 |
| Positive | 2 | 15 | 23 | |
| Histological grade | ||||
| II | 9 | 16 | 21 | 0.0335* |
| III | 5 | 18 | 48 | |
| ER | ||||
| Negative | 6 | 27 | 52 | 0.0261* |
| Positive | 8 | 7 | 17 | |
| PR | ||||
| Negative | 6 | 27 | 56 | 0.0079* |
| Positive | 8 | 7 | 13 | |
| Her-2 | ||||
| Negative | 5 | 22 | 46 | 0.0880 |
| Positive | 9 | 12 | 23 | |
| Ki-67 | ||||
| Low (≤15%) | 6 | 3 | 13 | 0.0232* |
| High (>15%) | 8 | 31 | 56 | |
Notes: All other values are shown as the number of cases and percentage (%). *p < 0.05.
Abbreviations: ER, estrogen receptor; PR, progesterone receptor; Her2, human epidermal growth factor receptor 2.